(Q44449309)

3 December 2017

title

Celecoxib is as efficacious as naproxen in the management of acute shoulder pain (English)

1 reference

3 December 2017

0 references

1 reference

P Bertin

1

1 reference

3 December 2017

J M Béhier

series ordinal

2

1 reference

3 December 2017

E Noël

series ordinal

3

1 reference

3 December 2017

J L Leroux

series ordinal

4

1 reference

3 December 2017

publication date

1 March 2003

1 reference

Journal of International Medical Research

3 December 2017

published in

1 reference

3 December 2017

volume

31

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

102-112

1 reference

Piroxicam in acute musculoskeletal disorders and sports injuries.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Piroxicam versus naproxen in the treatment of acute musculoskeletal disorders in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Effect of imidazo[1,2-a]pyrimidine derivatives on leukocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Celecoxib versus diclofenac in the management of osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Ultrasound therapy for musculoskeletal disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Nonpharmacological treatments for musculoskeletal pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Comparison of physiotherapy, manipulation, and corticosteroid injection for treating shoulder complaints in general practice: randomised, single blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

21 January 2018

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100206

10.1177/147323000303100206

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference